Lemaitre Vascular (LMAT) Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Operating Expenses for 17 consecutive years, with $30.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 5.32% year-over-year to $30.4 million in Q2 2026; TTM through Jun 2026 was $114.0 million, a 6.14% increase from a year earlier, with the FY2025 full-year figure at $110.6 million, up 12.15% from the prior year.
• Operating Expenses was $30.4 million for Q2 2026 at Lemaitre Vascular, down from $30.6 million in the prior quarter.
• Over five years, Operating Expenses peaked at $30.6 million in Q1 2026 and troughed at $18.0 million in Q1 2022.
• A 5-year average of $24.4 million and a median of $24.1 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 40.7% in 2022 and gained 2.76% in 2023, its largest moves.
• Over 5 years, Operating Expenses stood at $19.1 million in 2022, then rose by 20.81% to $23.1 million in 2023, then climbed by 11.61% to $25.7 million in 2024, then rose by 6.3% to $27.4 million in 2025, then climbed by 10.99% to $30.4 million in 2026.
• The last three Operating Expenses figures came in at $30.4 million (Q2 2026), $30.6 million (Q1 2026), and $27.4 million (Q4 2025), per Business Quant data.